Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05697939 · ClinicalTrials.gov registry record

3D Body Surface Modeling for Scoliosis Monitoring

A clinical trial of Adolescent Idiopathic Scoliosis, sponsored by Stanford University.

Recruiting
Registry status
13
Enrollment target
1
Study location

NCT05697939 is a study of Adolescent Idiopathic Scoliosis that is actively recruiting participants, run by Stanford University. The registered enrollment target is 13 participants, below the 276-participant average among 7 other Adolescent Idiopathic Scoliosis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05697939, a study of Adolescent Idiopathic Scoliosis, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
13 participants
Enrollment target
1
Study location

Study Summary

This is a single center, prospective, non-randomized reproducibility study of the NSite device in patients undergoing evaluation for scoliosis. The NSite device is a pre-market, investigational device. The study will enroll 13 eligible patients, who will be scanned using the NSite device by 3 separate users in order to assess if the device generates similar results across users. This data will be used to support 510(k) submission.

Interventions

  • DIAGNOSTIC_TEST NSite 3D Scanning

Study Locations (1)

California

  • Lucille Packard Children's Hospital and Clinics - Palo Alto

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2020-08-26
Est. Completion 2030-01-01

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05697939

The ClinicalTrials.gov registry entry for NCT05697939 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 276-participant average among 7 other Adolescent Idiopathic Scoliosis trials with a reported enrollment target (95% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adolescent Idiopathic Scoliosis appearing as the primary indexed condition, and to 1 intervention - of which NSite 3D Scanning is the first listed.

NCT05697939 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05697939 about?

NCT05697939 is a clinical study titled "3D Body Surface Modeling for Scoliosis Monitoring". This is a single center, prospective, non-randomized reproducibility study of the NSite device in patients undergoing evaluation for scoliosis. The NSite device is a pre-market, investigational device. The study will enroll 13 eligible patients, who will be scanned using the NSite device by 3 separa...

What is the current status of trial NCT05697939?

This trial is currently recruiting. The enrollment target is 13 participants. The study started on 2020-08-26. Estimated completion is 2030-01-01.

What conditions does trial NCT05697939 study?

This clinical trial studies the following conditions: Adolescent Idiopathic Scoliosis.

What interventions are being tested in trial NCT05697939?

The interventions under investigation include: NSite 3D Scanning (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05697939?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05697939 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent Idiopathic Scoliosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.